Quad’s Heartfelt Move: Extending Bank Debt Agreement to 2029

Quad/Graphics Completes Ninth Amendment to Bank Debt Agreement SUSSEX, Wis., Oct. 21, 2024 /PRNewswire/ — Quad/Graphics, Inc. (NYSE: QUAD), a global marketing experience company, announced today that it has completed the ninth amendment to the company’s bank debt agreement. This amendment includes various changes to the existing revolving credit facility and term loan facility, as…

Read More

Clever Collaboration: Atossa Therapeutics and Karolinska Institute to Discuss Preventing Breast Cancer at BIO EUROPE 2024

Atossa Therapeutics Announces Participation in BIO-Europe 2024 Join our CEO for a Fireside Chat on Breast Cancer Prevention SEATTLE, Oct. 21, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (NASDAQ: ATOS) (“Atossa” or the “Company”), today announced that Steven Quay, M.D., Ph.D., Chairman and Chief Executive Officer, will join Per Hall, M.D., Professor of Epidemiology at…

Read More

Collaboration for a Brighter Future: Bright Minds Biosciences and Firefly Neuroscience Join Forces After Successful BREAKTHROUGH Study

Bright Minds Biosciences Inc. Collaborates with Firefly Neuroscience Inc. for EEG Data Analysis Exciting Partnership for Neurological and Neuropsychiatric Disorders NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQ: DRUG), a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric…

Read More

Unlocking Potential: Latin Metals Secures Crucial Permit for Advancing Exploration at Esperanza Copper-Gold Project in San Juan Province, Argentina

Latin Metals Receives Key Permit for Esperanza Project Exploration VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) (OTCQB: LMSQF) Latin Metals Inc. is pleased to announce that it has received a key permit to begin exploration activities at the Esperanza project. This is…

Read More

Revolutionizing Supply Chain Performance: TECSYS Unveils Advanced Data Science and Technology Tools in Latest Release

Charmingly eccentric, full of personality, and designed for maximum reader engagement Data-driven operational control and efficiency prominently featured in Elite™ 24.2 release MONTREAL, Oct. 21, 2024 /PRNewswire/ — Tecsys Inc. (TSX: TCS), a global leader in supply chain management solutions has introduced new advanced capabilities in its Elite™ software platform that help businesses achieve a…

Read More

Meet the Newest Addition to Our Board: Mert Aktar Joins the Kyverna Therapeutics Team!

Welcome to the Kyverna Therapeutics Blog! A New Addition to the Board Hey there, fellow biopharmaceutical enthusiasts! Have you heard the exciting news? Kyverna Therapeutics, a cutting-edge clinical-stage company specializing in cell therapies for autoimmune diseases, has just appointed the talented Mert Aktar as an independent director on their Board of Directors. This is big…

Read More